NuCana Hauls In $57 Million
4/11/2014 6:43:25 AM
Sofinnova Ventures is leading a $57 million financing for NuCana BioMed Ltd ., which is developing better versions of existing chemotherapy drugs at a time when much of the pharmaceutical industry is trying to discover new, molecularly targeted cancer therapies.
Help employers find you! Check out all the jobs and post your resume.
comments powered by